Clinical Trial Update: A Study of LY3015014 in Otherwise Healthy Participants With High Low-density Lipoprotein (LDL) Cholesterol [Phase 1]

View source ↗

Summary

Phase 1 trial update for LY3015014 in otherwise healthy participants with high LDL cholesterol has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apheresis-related Indications
• Hyperlipidemia

Drugs mentioned

• LY3015014

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2019-02-25